Author:
Schmitt Claus,Lehmann Gu¨nter,Schmieder Sebastian,Karch Martin,Neumann Franz-Josef,Scho¨mig Albert
Subject
Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine
Reference51 articles.
1. Late assessment of thrombolytic efficacy (LATE) study with alteplase 6–24 hours after onset of acute myocardial infarction;Hampton;Lancet,1993
2. Gruppo Italiano per lo studio della sopravvivenza nell'infarto miocardico. GISSI-2: a factorial randomised trial of alteplased versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction;Lancet,1990
3. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2;ISIS-2 (second international study of infarct survival) collaborative group;Lancet,1988
4. ISIS-3: A randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction;ISIS-3 (third international study of infarct survival) collaborative group;Lancet,1992
5. Continuous ST-segment monitoring associated with infarct size and left ventricular function in the GUSTO-I trial;Moons;Am Heart J,1999
Cited by
91 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献